HendyBe Biotech Co., Ltd., headquartered in China, is a leading player in the biotechnology industry, specialising in innovative solutions for healthcare and agricultural applications. Founded in 2015, the company has rapidly established itself as a key provider of advanced biotechnological products, focusing on enzyme development and microbial fermentation. With a commitment to research and development, HendyBe has achieved significant milestones, including the launch of proprietary enzyme formulations that enhance productivity in various sectors. Their unique offerings are designed to improve efficiency and sustainability, setting them apart in a competitive market. Recognised for their contributions to biotechnology, HendyBe Biotech has garnered a strong market position, serving clients across Asia and beyond. Their dedication to quality and innovation continues to drive their success in the ever-evolving biotech landscape.
How does HendyBe Biotech Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
HendyBe Biotech Co., Ltd.'s score of 10 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HendyBe Biotech Co., Ltd., headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. This lack of emissions data and formal commitments suggests that HendyBe Biotech may be in the early stages of developing its climate strategy or may not yet be actively engaged in comprehensive emissions reporting. As the biotech industry increasingly prioritises sustainability, it is essential for companies like HendyBe Biotech to consider setting measurable targets and participating in initiatives such as the Science Based Targets initiative (SBTi) to align with global climate goals. Without specific emissions data or reduction initiatives, the company may face challenges in demonstrating its commitment to addressing climate change and reducing its environmental impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
HendyBe Biotech Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
